1 most recent filing and news item mentioning LXRX. Updated every 60 seconds.
Guidance|RegulatoryAug 6, 2026Positive
Lexicon Pharmaceuticals announces completed enrollment for SONATA-HCM with Q1 2027 topline data expected; NDA resubmission for ZYNQUISTA in Type 1 diabetes nearing completion.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.